Wells Fargo
MAIA icon

Wells Fargo’s MAIA Biotechnology MAIA Stock Holding History

Wells Fargo’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288 Buy
+200
New +$266 ﹤0.01% 6564
2024
Q2 		– Sell
-91
Closed -$200 – 7233
2024
Q1 		$200 Buy
91
+22
+32% +$33 ﹤0.01% 6494
2023
Q4 		$81 Buy
69
+6
+10% +$10 ﹤0.01% 6820
2023
Q3 		$139 Buy
63
+29
+85% +$57 ﹤0.01% 6677
2023
Q2 		$75 Buy
34
+20
+143% +$53 ﹤0.01% 6941
2023
Q1 		$48 Hold
14
– – ﹤0.01% 7121
2022
Q4 		$49 Hold
14
– – ﹤0.01% 7010
2022
Q3 		$0 Buy
+14
New +$59 ﹤0.01% 7076

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wells Fargo's MAIA Position: Q2 2026 in Review

Wells Fargo opened a new position in MAIA Biotechnology (MAIA) in Q2 2026: 200 shares worth $288. The stake represents ﹤0.01% of the portfolio and ranks #6564 among its holdings. This is a return to the name: Wells Fargo previously reported a position in MAIA as recently as Q1 2024.

Wells Fargo first reported a position in MAIA in Q3 2022 and has held it in 8 quarters since. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Wells Fargo held 200 shares of MAIA Biotechnology worth $288 as of Q2 2026.
  • MAIA Biotechnology was a new Wells Fargo position in Q2 2026.
  • MAIA Biotechnology made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6564 holding.
  • Wells Fargo first reported a position in MAIA Biotechnology in Q3 2022 and has held it in 8 quarters since.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.